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Inhibition of a ribosome-inactivating ribonuclease: the crystal
structure of the cytotoxic domain of colicin E3 in complex with
its immunity protein
Stephen Carr1, Daniel Walker2, Richard James2, Colin Kleanthous2
and Andrew M Hemmings1,2*
Background: The cytotoxicity of most ribonuclease E colicins towards
Escherichia coli arises from their ability to specifically cleave between bases
1493 and 1494 of 16S ribosomal RNA. This activity is carried by
the C-terminal domain of the colicin, an activity which if left unneutralised
would lead to destruction of the producing cell. To combat this the host
E. coli cell produces an inhibitor protein, the immunity protein, which forms
a complex with the ribonuclease domain effectively suppressing its activity.
Results: We have solved the crystal structure of the cytotoxic domain of the
ribonuclease colicin E3 in complex with its immunity protein, Im3. The structure
of the ribonuclease domain, the first of its class, reveals a highly twisted central
β-sheet elaborated with a short N-terminal helix, the residues of which form a
well-packed interface with the immunity protein. 
Conclusions: The structure of the ribonuclease domain of colicin E3 is
novel and forms an interface with its inhibitor which is significantly different
in character to that reported for the DNase colicin complexes with their
immunity proteins. The structure also gives insight into the mode of action
of this class of enzymatic colicins by allowing the identification of
potentially catalytic residues. This in turn reveals that the inhibitor does not
bind at the active site but rather at an adjacent site, leaving the catalytic
centre exposed in a fashion similar to that observed for the DNase colicins.
Thus, E. coli appears to have evolved similar methods for ensuring efficient
inhibition of the potentially destructive effects of the two classes of
enzymatic colicins.
Introduction
Colicins are plasmid-encoded protein antibiotics pro-
duced by strains of Escherichia coli and closely related bac-
teria. They are classified into groups corresponding to the
cell-surface receptor to which they bind; for example, the
E colicins bind to the product of the chromosomal btuB
gene, a receptor involved in the high-affinity transport of
vitamin B12 [1]. Killing of E. coli cells by E colicins occurs
in three stages: receptor binding, translocation and cyto-
toxicity. E colicin proteins consist of three domains, each
of which has been implicated in one of these stages. The
central (R) domain is responsible for the binding of the
colicin to the btuB receptor, whereas the subsequent
translocation across the cytoplasmic membrane involves
the N-terminal (T) domain of the toxin interacting with
various components of the E. coli Tol translocation
system. The mechanism of cytotoxicity of E colicins
results from either cytoplasmic membrane depolarisation
(colicin E1) [2], a non-specific endonuclease activity that
degrades DNA (colicins E2, E7, E8 and E9) [3–5] or a
ribonuclease activity that cleaves specific transfer RNAs
(colicin E5) [6] or16S ribosomal RNA (colicins E3, E4
and E6) [7,8]. 
Colicin E3 is a 58 kDa RNase colicin which kills sensitive
cells by a process of ribosome inactivation. The cytotoxic
activity is associated with the 11 kDa C-terminal domain
of the colicin (96 amino acids) which can be isolated as a
folded, active protein fragment [9]. The mode of action
in vivo involves a nucleolytic break of E. coli 16S ribosomal
RNA. The same cleavage has been observed in vitro by
incubation of colicin E3 with isolated ribosomes [10]. The
cleavage is specific and occurs between bases 1493 and
1494, 48 nucleotides from the 3′-end of the 16S RNA [11]
and results in total inactivation of peptide synthesis.
Adenine 1493 is located within the ribosomal A-site and is
protected from dimethyl sulphate modification by mRNA-
dependent tRNA binding. This suggests that this residue
is in the immediate vicinity of the codon–anticodon
complex formed during peptide synthesis [12].
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The resistance of the producing bacteria to the toxic
effects of colicin E3 is afforded by the presence of the
9.8 kDa immunity protein (Im3). This binds to the C-ter-
minal domain of colicin E3 in a 1:1 stoichiometry which
renders the toxin completely inactive [9]. Mutagenesis of
Im3 reveals that Cys47 is the most important specificity
determining residue in the colicin E3–Im3 interaction
[13]. Asp15 and Glu19 were also implicated in colicin
specificity but mutation of these has much less effect on
colicin binding. Although no structure for an RNase
colicin exists, the structure of Im3 has been reported
recently [14,15]. This revealed a crystallographic dimer
with the monomer consisting of a four-stranded antiparal-
lel β sheet with two short helices packing against one face.
Residues Cys47, Asp15 and Glu19 all fall on the same
inner face of the β sheet in the immunity protein dimer
and so it was proposed that this is the site of interaction
with the toxin. 
In contrast to the RNase colicins, the interaction of DNase
colicins with their immunity proteins has been well-studied
[16]. The association between the colicin E9 DNase
domain and Im9 has been extensively characterised and
displays one of the tightest protein–protein interactions yet
reported (Kd = 10–16 M) [17]. To date, no binding affinity
studies have been performed for the RNase colicins
although a dissociation constant of a similar magnitude is
expected as the E3–Im3 complex can only be dissociated
under strongly denaturing conditions [18]. The amino acid
sequence at the interface between colicin E9 and Im9 has
been shown to contain two distinct regions: the first is con-
served and constitutes a binding energy hot-spot whereas
the second is variable and determines specificity [19,20].
The cytotoxic domain of the RNase colicins displays a
much greater sequence conservation (80%–90% as shown
in Figure 1) than that observed for the DNase colicins
endonuclease domain (70%–80%). This implies that immu-
nity binding specificity is governed by fewer residues than
for DNase colicin–immunity protein complexes.
The cytotoxic domains of the DNase colicins E7 and E9
in complex with their respective cognate immunity pro-
teins have been structurally characterised [21,22]. However,
no structural data is available for the enzymatic RNase col-
icins, although the crystallisation of colicin E3 in complex
with its immunity protein has been reported [23]. Here we
report the crystallographic structure determination of
colicin E3 RNase domain bound to Im3 with a view to
understanding its ribosome-inactivating properties and its
inhibition by immunity protein binding. 
Results and discussion
Crystal structure of the colicin E3 RNase–Im3 complex
Crystals of the E3–Im3 complex were prepared which dif-
fracted to 2.4 Å resolution [24]. A selenomethionine deriva-
tive was prepared and the structure was solved by selenium
multiwavelength anomalous diffraction (Se-MAD) (Tables 1
and 2). The refined structure contains residues 1–96 of the
RNase domain (corresponding to residues 455–551 of
colicin E3), residues 1′ to 84′ of the immunity protein and
177 water molecules (Figure 2a). Eight residues (amino
acids 447–454 of colicin E3) present in the gene construct
are disordered and not visible in the electron-density maps.
The model of the E3–Im3 complex displayed in Figure 2
reveals that both proteins contain predominantly β structure
with only a limited occurrence of α helices. The molecular
interface between E3 and Im3 is formed between strands 1
and 2 of the ribonuclease packing across the exposed face of
the β sheet in Im3, with the N-terminal helix of the ribo-
nuclease domain wrapping across the top of the immunity
protein. This leads to an arrangement within the complex
where the β sheet in E3 lies perpendicular to that in Im3.
This type of packing is markedly different to that observed
in other protein–protein complexes involving β sheets
where complexation occurs by the sheets packing edge to
edge as found, for example, in the immunoglobulin–protein
G complex (Protein Data Bank [PDB] accession code 1igc
[25]) or the TolA N-terminal domain–g3p protein complex
(accession code 1tol [26]). 
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Figure 1
Sequence alignment of (a) the RNase
E colicin cytotoxic domains and (b) immunity
proteins. The boxed residues represent the
regions of each protein involved in binding.
Non-conserved residues are shown in red
and potential catalytic residues are
displayed in green. 
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Structure
The fold of the ribonuclease domain consists of two major
features: a short N-terminal α helix and a C-terminal
antiparallel β sheet that comprises the bulk of the sec-
ondary structure of this domain. The N-terminal helix
spans residues 1–10 of the ribonuclease domain (residues
456–465 of colicin E3) and is attached to the main β sheet
by an extended peptide which, although ordered, displays
no defined secondary structure and is termed the linker
coil. It is interesting to note that the N-terminal helix con-
tacts the rest of the ribonuclease solely through the linker
coil and forms non-bonding interactions exclusively with
the immunity protein. The linker coil immediately pre-
cedes the major sheet, which contains six strands (labelled
strands 1–6) and is highly super-twisted. Residues located
after the β structure fold across one end of the sheet and
the extreme C-terminal residues Tyr95 and Leu96 hydro-
gen-bond to residues in strand 2 (predominantly the
sidechain of Arg42) to hold this loop in place and gener-
ates a border to the concave surface of the RNase sheet.
The fold of the E3 RNase domain is significantly different
to that observed for other ribonucleases such as α-sarcin (a
eukaryotic protein that specifically cleaves 28S RNA
[27]) — which consist of an α helix packing across a four-
stranded antiparallel β sheet — suggesting this could form
the basis of a new family of ribonucleases. Structural
homology searches using the program DALI [28] and
TOP [29] also failed to reveal any significant homology
between the E3 structure and any other known fold,
implying that the structure is unique. 
The fold of Im3 has been described elsewhere [14,15], but
briefly consists of a four-stranded antiparallel β sheet
(strands 1′–4′) and two α helices. The helices both pack
against one face of the β sheet to produce an asymmetric
structure in which the sheet has one protected face (that
against which the helices pack) and one exposed face.
Comparison of free and bound Im3 structures
The X-ray structure of uncomplexed Im3 reveals a crystal-
lographic dimer. The constituent monomers can be super-
imposed to reveal any conformational heterogeneity in the
structure (root mean square deviation [rmsd] for backbone
atoms of 0.77 Å). This analysis reveals that Im3 is a rela-
tively rigid molecule with only slight movement seen in
the loop regions spanning residues 9′–16′, 39′–45′ and the
extreme C-terminal residues. However, when the struc-
tures of complexed and uncomplexed Im3 are compared
(Figure 3) a larger deviation is seen (rmsd of 0.92 Å). This
is manifested as a pronounced movement in the loop
spanning residues 39′–45′. The backbone moves outwards
through 4.3 Å and residues Phe39′ and Lys40′ rotate away
from Im3 to form a wide hydrophobic groove at the top of
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Table 1
Data collection statistics for the E3–Im3 complex.
Data set E1 E2 E3 Native
Wavelength (Å) 0.9795 0.979 0.9 0.95
Resolution (Å) 2.8 2.8 2.8 2.4
Completeness (%) 99.2 (94.4) 99.8 (98.2) 99.8 (99.6) 98.7 (97.5)
Anomalous completeness (%) 99.0 (96.0) 99.1 (95.2) 75.9 (66.0) –
Rsym* (%) 5.4 (24.6) 6.2 (25.5) 6.7 (22.3) 3.9 (23.7)
<I/σI> 21.1 (4.1) 23.3 (4.7) 22.3 (5.0) 37.8 (2.8)
Overall B factor 92.1 92.2 91.9 79.3
Anomalous multiplicity 4.8 4.7 4.2 –
SOLVE FOM† 0.55 (0.28)
Figures in parentheses refer to data in the highest resolution bin
(either 2.8–2.9 Å or 2.4–2.45 Å). *Rsym = Σ Σ | Ii – <I> | / Σ Ii,
where <I> is the average of symmetry-equivalent reflections and
the summation extends over all observations for all unique
reflections. †Average figure of merit (FOM) calculated by the SOLVE
program [45]. 
Table 2
Refinement statistics.
Resolution range (Å) 30–2.4
Rcryst* (%) 19.2 (19.4)
Rfree† (%) 22.8 (22.9)
Rmsd
bonds (Å) 0.021
angles (º) 1.86
Number of solvent molecules
water/ethylene glycol 177/1
Average B factor, mainchain (Å2)
E3 50.8
Im3 47.4
Average B factor, sidechain (Å2)
E3 55.9
Im3 49.3
B factor rmsd mainchain 1.7
B factor rmsd sidechain 2.2
Average solvent B factor (Å2)
water/ethylene glycol 62.3/47.9
Figures in parentheses refer to data in the highest resolution bin (either
2.8–2.9 Å or 2.4–2.45 Å). *Rcryst = Σ ||Fo| – |Fc|| / Σ|Fo|, where Fo and Fc
are the observed and calculated structure factors, respectively, and the
summation extends over all unique reflections in the quoted resolution
range for which F > 2.0σ (F) (i.e. the working set comprised 92.3% of
unique reflections). †For Rfree the summations extends over a subset
(5%) of reflections excluded from all stages of refinement.
the immunity protein which interacts extensively with the
N-terminal helix of the RNase domain. The rest of the
backbone is essentially unperturbed on complexation but
sidechains Phe9′, Phe16′ and Phe74′ all rotate significantly
owing to their specific interaction with residues in E3.
The protein–protein interface 
The exposed face of the four-stranded β sheet in Im3 is
the major site of interaction with the E3 RNase domain.
Residues in the groove formed by the movement of loop
residues 39′–45′ also make a number of contacts with the
RNase. When mapped onto the primary sequence these
residues form four discrete regions located throughout the
entire length of the protein. In contrast to this the residues
involved in binding in the RNase domain all fall within
the N-terminal half of the protein (the last residue
involved in binding is Lys41) and consist of just two elon-
gated binding regions (Figure 1). Structurally, the residues
in the RNase domain involved in binding fall on the lower
face of the short N-terminal helix, the linker coil and the
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Figure 2
Crystal structure of the E3–Im3 complex at
2.4 Å resolution. (a) Stereo diagram showing
the Cα trace of the complex with every tenth
residue labelled. (b) Overview of the E3–Im3
complex with the helices and strands of the
RNase coloured red and green, respectively,
and the immunity protein displayed in blue and
yellow. (c) Stereoview of the electron density
surrounding the specificity determining
residue Cys47′ of the immunity protein.
This can be seen to reside in a large cavity
containing four well-ordered water molecules
and an ethylene glycol molecule.
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first two strands of the β sheet. The solvent-accessible
areas calculated for each of the proteins when separated
are 6631 Å2 and 5172 Å2 for E3 and Im3, respectively. On
complexation the total accessible surface area buried is
2554 Å2 corresponding to the loss of 1374 Å2 for E3 and
1180 Å2 for Im3 (Figure 4a). This is a much greater loss of
surface area compared to that occurring on complexation
of barnase and barstar (1590 Å2) [30] or either of the
DNase colicin immunity complexes analysed to date
(1575 Å2 for colicin E9–Im9 and 1473 Å2 for colicin
E7–Im7) [21,31]. 
The molecular surfaces at the interface colour-coded by
electrostatic potential are shown in Figure 4b. The inter-
face is highly charged and also displays charge comple-
mentarity with the basic RNase domain and an acidic
immunity protein. The most acidic surface areas in Im3,
located in the immediate vicinity of Asp5′ and Asp78′,
interact with the most prominent basic area of E3, centred
around Lys41. These electrostatic interactions — due to
their long range nature — could be involved in the elec-
trostatic steering and pre-orientation of each molecule
before binding, as well as contributing significantly to the
interaction energy on complexation. Figure 4c shows the
hydrophobic residues present at the interface. This
clearly indicates the presence of a hydrophobic patch
directly beneath the most acidic and basic regions of E3
and Im3, respectively. In addition, a significant hydropho-
bic pocket is seen in the open groove at the top of Im3,
this complements the hydrophobic residues present in the
N-terminal helix of E3. The organisation of hydrophobic
and hydrophilic interactions across the open groove is
typical in that the hydrophobic pocket is surrounded by
polar residues [32]. However, in the main body of the
interface this distribution is much less apparent as the
hydrophobic patch is at the base of the interface and
flanked by a single polar interaction (Im3 Glu14′–E3
Lys30) on one side and an extensive hydrophilic patch
on the other. 
The surface complementarity index was calculated using
the program Sc [33] and a value of 0.7 was obtained. This
degree of complementarity is at the upper end of a scale
between 0 (no complementarity) and 1 (perfect comple-
mentarity) and is remarkable considering the area buried
as other proteins with similar values generally have smaller
interfaces. The complementarity index has the same value
as that obtained for the barnase–barstar complex and being
high suggests highly complementary surfaces — implying
the presence of few gaps at the interface. This was con-
firmed by calculation of the interfacial gap volume
(SURFNET [34]) revealing a total gap volume of 3398 Å3
which, when normalised to give the gap volume index,
produces a value of 1.34 Å. This is significantly lower than
the average calculated for ten test enzyme–inhibitor com-
plexes, which gave a value of 2.2 Å [35].
Analysis of the surface area buried on complexation at the
amino acid level identifies the residues participating in
binding. In Im3, residues Glu14′ (51 Å2), Phe16′ (64 Å2),
Phe39′ (38 Å2), Asp41′ (78 Å2), Asn44′ (85 Å2), Asn45′
(84 Å2), Cys47′ (74 Å2), Tyr79′ (67 Å2), Arg80′ (66 Å2) and
Asp81′ (50 Å2) are most deeply buried (loss of > 50 Å2) at
the interface reiterating the presence of both hydrophobic
and hydrophilic interaction at the interface. In E3 the
most deeply buried residues at the interface are: Phe2
(168 Å2), Lys3 (64 Å2), Tyr5 (74 Å2), Tyr9 (82 Å2), Pro11
(75 Å2), Lys14 (80 Å2), Pro26 (79 Å2), Ile28 (115 Å2), Pro29
(51 Å2), Lys39 (72 Å2) and Lys41 (93 Å2). The hydropho-
bic residues Phe2 and Ile28 can be seen to contribute
extensively to the overall buried surface area.
There are a total of 15 direct hydrogen bonds with distances
less than 3.2 Å at the E3–Im3 interface, a comparable
number to that seen in the DNase colicin complexes
E7–Im7 and E9–Im9, both of which contain 12 hydrogen
bonds. Considering the size of the interfaces, however, the
density of hydrogen bonds is significantly lower in E3–Im3
than observed elsewhere. On average, 1.37 hydrogen bonds
are formed per 100 Å2 of interface in ten enzyme–inhibitor
complexes [35]. However, in the E3–Im3 complex only
1.17 hydrogen bonds are identified per 100 Å2 of interfacial
area. The sparse nature of hydrogen bonding arises
because, although a large surface area is buried, the
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Figure 3
Schematic representation of the superposition of the fold of Im3 from
the Em3–Im3 complex with that of free Im3. The uncomplexed protein
is shown in green and the complexed protein in red. 
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Figure 4
Surface representations of each component
of the E3–Im3 complex oriented to display the
interacting surfaces. In each case E3 is
shown on the left and Im3 on the right.
(a) The buried residues are coloured
according to the amount of accessible area
lost on complexation, with yellow
corresponding to the least (0–29 Å2),
followed by blue (30–60 Å2) and red
(> 60 Å2). The highlighted residues are those
which undergo the greatest loss of surface
area on complexation. (b) The interface
coloured by electrostatic potential; red areas
correspond to acidic residues and blue
regions to basic residues. (c) The hydrophobic
residues buried on complexation are
highlighted in green. (d) The conservation of
residues at the interface colour-coded on the
basis of the sequence alignment in Figure 1.
The residues coloured yellow are totally
conserved, whereas blue residues display
some mutational variability, and red regions
correspond to non-conserved residues. The
labelled residues correspond to those thought
to be involved in specificity. 
hydrophilic interactions are localised to the upper region
of the interface while the rest of the buried surface dis-
plays entirely hydrophobic characteristics (Figure 4c). Of
the 15 hydrogen bonds, five involve both charged donor
and acceptor groups and four others involve one charged
group, which should make significant contributions to the
free energy change of dissociation [36]. Therefore
although the E3–Im3 complex contains a similar number
of hydrogen bonds to the DNase colicin complexes and the
barnase–barstar complex (containing 14 direct hydrogen
bonds) [30] their density at the interface is lower, thus
implying hydrophobic burial may be more intimately linked
with the dissociation energy than in other nuclease–inhibitor
complexes. Within the hydrophobic areas the majority of
the interactions are observed to be either the stacking of
aromatic rings or the interaction of aromatic rings with
large aliphatic residues such as isoleucine. Studies of
protein–inhibitor complexes have revealed that the largest
values of buried accessible surface area are associated with a
significant conformational change in one of the two proteins
on complexation. As shown above, the structure of Im3 is
not significantly altered on complexation and until the
structure of the free RNase is determined we should 
not neglect the possibility that significant changes in the
structure of the RNase domain may be contributing to the
large buried surface area of the interface. 
The direct interactions at the molecular interface can be
separated into two regions based on the structure of E3.
The first corresponds to the N-terminal helix and its imme-
diate vicinity (E3 residues 1–12, Figure 5a), while the
second corresponds to the interacting residues in the β sheet
of E3 (residues 26–41, Figure 5b). The α helix in E3 dis-
plays extensive interactions with residues forming the open
groove in Im3. E3 residue Phe2 is in van der Waals contact
with several residues in Im3 including Leu2′, Phe39′ and
Tyr79′ — residues which form the hydrophobic pocket seen
in Figure 4c. Tyr5 from E3 also packs against Phe39′. As
well as participating in hydrophobic interactions the back-
bone oxygen of Tyr5 forms two water-mediated hydrogen
bonds to the mainchain oxygen atoms of both Phe39′ and
Val43′. The positive charge of Lys3 is compensated by the
acidic group Asp81′, while the lower region of the sidechain
packs against the aromatic ring of Tyr79′. The sidechain of
His7 forms a bifurcated hydrogen bond to the charged head
group of Asp81′ forming one of the major interactions in this
region. The hydroxyl group of Tyr9 also forms a hydrogen
bond to a charged acceptor (Asp41′). Immediately adjacent
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Figure 5
Stereoview representations of some of the
specific interactions occurring on E3–Im3
complex formation. Residues from the
immunity protein are coloured light grey while
residues from the RNase are black and
labelled in bold type. (a) Interactions at the
N-terminal helix involving the insertion of the
Phe2 sidechain into a hydrophobic pocket
and the formation of several salt bridges and
hydrogen bonds. (b) Interactions involving the
β-sheet region of E3 displaying several salt
bridges and hydrophobic contacts.
to the N-terminal helix, Ala12 forms direct and water-medi-
ated hydrogen bonds to the sidechains of Arg80′ and Asn44′,
respectively. The residues within the β sheet on E3 at the
interface (26–41) interact with residues across the face of the
β sheet of Im3. The hydrophobic residues involved in
immunity binding in this region are Pro26, Ile28 and Pro29.
Pro26 packs against both Phe9′ and Phe16′, while Ile28
interacts with Phe9′ and Phe74′. Pro29 is in van der Waals
contact with the aromatic ring of Phe74′ alone. Lysine
residues 39 and 41 are extremely important in terms of Im3
binding as both are deeply buried on complexation and also
form multiple contacts with residues in Im3. Lys39 forms
two mainchain hydrogen bonds to the backbone carbonyl
and amide groups of Cys47′, a residue implicated in immu-
nity specificity between the RNase colicins E3 and E6 [14].
The sidechain of Lys39 forms a salt bridge with the car-
boxylic acid group of Asp49′. Lys41 forms two salt bridges
with residues Asp5′ and Asp78′ and the highly buried
nature of Lys41 on complexation is likely to greatly
increase the strength of these interactions. Surface burial
analysis does not implicate Ser56 as an interfacial residue,
however, its sidechain is oriented such that it forms two
direct hydrogen bonds to residues Asn44′ and Asn45′.
Asp15′ and Glu19′ have been implicated in Im3 binding
due to the lack of conservation displayed at these positions
[8,14]; however, the structure reveals that these residues
are not involved in binding at all.
The role of water at the molecular interface
Surface area analysis of the ordered water molecules
revealed the presence of 23 water molecules in the vicin-
ity of the molecular interface (Figure 6). Of these 12 are
completely buried, whereas the remainder have an acces-
sible area of < 5 Å2. The average temperature factor of
these water molecules is 53.4 Å2, a value comparable to
that for the residues in both protein chains (E3, 53.3 Å2;
Im3, 48.3 Å2) indicating that they are well ordered. Six of
the water molecules are involved in water-bridged hydro-
gen bonds and a further three participate in double-water-
bridged hydrogen bonds (of the type E3–water–water–Im3).
The remaining 14 water molecules lie much closer to
either E3 or Im3 and could represent some of the hydra-
tion shell of each protein before complexation. One line of
evidence to support this assertion comes from the super-
position of Im3 from the complex onto the free immunity
protein [14,15]. This reveals that seven of the water mol-
ecules at the complex interface occupy very similar posi-
tions to water molecules observed in the free Im3
structure. When included in the gap volume calculation,
the gap volume index was reduced to 1.12. This indicates
that water has a dual role at protein interfaces forming
additional interactions between the proteins and filling in
gaps between macromolecular surfaces. The latter func-
tion should lead to an increase in complementarity at the
interface and when the Sc coefficient was recalculated
including the buried water molecules a value of 0.71 was
found indicating a slight increase in complementarily.
This very slight increase in complementarity has been
observed for several other protein complexes [34]. It is
likely that water molecules bind at areas of particularly
poor complementarity and so only cause a local improve-
ment. As the Sc coefficient is the median of the comple-
mentarity calculated for small subsections of the interface,
an improvement in the areas of very poor fit has little
effect on the overall Sc value.
Sequence conservation and specificity of immunity protein
binding
The RNase E colicins display a very high degree of
sequence identity and as such the specificity of each colicin
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Figure 6
Surface representation of the interacting
surfaces of colicin E3 and Im3 showing water
molecules that display less than 5 Å
accessible surface area on complex formation.
Many of the waters are positioned to fill clefts
on the interacting surfaces of each protein
(water molecules involved in hydrogen-
bonding interactions to both proteins are
shown in dark blue). Water molecules
conserved in position between this structure
and that of the free immunity protein [14]
are coloured magenta.
to its cognate inhibitor protein will be dictated by a few
residues. Sequence alignment of the RNase colicins and
cloacin DF13 reveals the presence of seven non-con-
served residues which are involved in interactions
between the proteins (Figures 1 and 4d). To ascertain
whether these residues may be involved in immunity
specificity the variability of the amino acids in Im3 with
which they interact was analysed. It is seen that Ala12 and
Pro26 both interact with totally conserved residues in Im3
and that the sidechain of Lys39 retains its positive nature
among the RNases and forms a salt bridge with the com-
pletely conserved Asp49′ suggesting none of these residues
have a role in specificity. Ile28 is also unlikely to have a
role in specificity based on this analysis. Residue 41
(lysine in E3) is extremely variable and is the only basic
residue in this position in the homologous proteins. It is
therefore a good candidate to be involved in specific
binding of Im3 to E3. One of the partner residues of
Lys41 (Asp78′) is totally invariant and so the highly acidic
patch seen in Figure 4a retains some of its charged charac-
ter in the other RNase colicins. However, residue 5′ (aspar-
tic acid in Im3), which also contributes to the interfacial
acidic patch on Im3, displays the same degree of variabil-
ity as Lys41 yet complementarity can be seen between
the mutations at both these positions, confirming the
specificity-defining nature of these residues. Phe2 appears
to be involved in specificity in a more indirect manner. In
the homologous sequences smaller amino acids occupy
this position (valine and threonine), but the residues
forming the hydrophobic pocket with which it interacts
are invariant or mutated in a conserved manner. This
implies the burial of hydrophobic surface is much greater
for E3 than any other protein, increasing the strength of
interaction at this site and thus aiding in specific binding
of Im3. Pro29 is conserved between E3 and E6 but is
mutated to lysine in E4. In Im4 a compensatory F74′Q
mutation occurs and so this is likely to facilitate specificity
between E4 and Im4. Asp5′ and Cys47′ are the sole vari-
able residues in Im3. The former is involved in interac-
tions with Lys41, whereas the latter interacts with the
backbone of Lys39. Cys47′ has been implicated in specific
binding to E3 by experiments using chimeric Im3/Im6
proteins [14]. As backbone atoms are involved in the
hydrogen bonds formed between Lys39 and Cys47′ it is
likely that specificity resides in the sidechain of Cys47′.
However, the structure reveals the cysteine residue to be
located in a large open pocket flanked by E3 residues
Pro29 and Lys41 and does not form any direct contacts
with any residue (Figure 1). Therefore the role of Cys47′
in specificity determination is not obvious. The immunity
protein also displays a significant lack of sequence conser-
vation on the protected face of the β sheet and the α
helices. This is in marked contrast to the DNase colicins
which display their most significant sequence heterogene-
ity at the site of DNase binding. As the second site of
sequence variation is located in a discrete region of the
immunity protein it could represent a second site of spe-
cific interaction between the colicin and immunity protein.
This would lead to a tighter toxin–immunity protein inter-
action and hence afford even greater host protection.
The active site and inhibition of RNase activity
As the fold of the E3 domain appears to be unique no cat-
alytic residues could be identified by simple comparison
to other RNases. However, a number of residues have
been implicated in the activity of this toxin by a variety of
methods. The activity of colicin E3 is sensitive to modifi-
cation with diethyl pyrocarbonate (DW and CK, unpub-
lished results) and this, when combined with the
observation that histidines are invariably located at the
active site of RNases, indicates that at least one histidine
is involved in catalysis. Of the four histidines found in E3
(at positions 7, 10, 58 and 71), two (residues 7 and 58) are
more likely to be involved in RNA hydrolysis, as His10 is
non-conserved between the homologous proteins E3, E4,
E6 and cloacin DF13, while His71 is entirely buried in the
E3 monomer structure. Sequence alignment techniques
have also been used to suggest a potential catalytic role for
one or both of these histidines (7 or 58) as well as reveal-
ing a conserved arginine residue at position 42 [37]. This
arginine has been postulated to have a role in RNA
sensing [38], although this may not be the case in E3 as
this residue hydrogen bonds to the C-terminal residues of
the enzyme and might be necessary to maintain the
RNase structure. Two mutations which abolish activity
have also been identified within this domain (G59D and
S74L) [39]. From analysis of the structure it appears that
both of these are likely to have lost activity by an alter-
ation of the conformation of the protein rather than being
directly involved in catalysis.
As mutational analysis to locate the catalytic residues is
yet to be performed, the active-site residues of two previ-
ously well-characterised RNases (RNase A, PDB code
1afk [40] His–His catalytic pair and barnase, PDB code
1a2p [41] His–Glu catalytic pair) were used to generate
fingerprints of the relative positions of catalytic residues.
These fingerprints were then used to probe the surface of
the E3 RNase in order to locate potential active site
residues. The potential catalytic residue His7 is located at
the surface of the RNase and is in direct contact with Im3.
This could indicate a role in catalysis as it interacts with
Im3 in a manner which could lead to inactivation of the
toxin, as the hydrogen bonds formed between His7 and
Asp81′ could orientate the imidazole sidechain group in
such a way as to prevent nucleolytic activity. It is possible
to superimpose His7 and His10 onto the catalytic histi-
dine pair of RNase A with an rmsd of 1.7 Å (calculated
using all sidechain atoms in the residues mentioned
above), however, it is unlikely that this represents the
actual catalytic pair as His10 is a non-conserved residue
and there are no basic residues in the vicinity to stabilise
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the transition state of the nucleolytic reaction. Of the
numerous alternative pairs also tested the His10–His58
pair are near a basic residue (Lys33) producing a potential
active site (rmsd to RNase A active site 1.4 Å). However,
this putative active site contains the non-conserved His10
and both the mainchain and sidechain of Gln57 are orien-
tated such that they protrude into the region between
these residues, suggesting that these are not involved in
activity. Alternatively, His58, located some distance from
Im3 is found adjacent to a basic residue (Arg90) and to
Glu62. Least squares superposition of all common
sidechain atoms in these residues was performed against
the barnase catalytic residues (His102, Glu73 and Lys27)
and revealed an rmsd of 1.3 Å. This alignment also places
the basic head group of Lys84 from E3 in the same posi-
tion as that of the barnase active-site residue Arg87, sug-
gesting they perform similar roles during the reaction
cycle. However, the barnase active-site residue Arg83
appears to have no structural homologue in colicin E3
based on this analysis. His58, Glu62, Lys84 and Arg90 are
totally conserved throughout the ribonuclease colicins
and the tetrad is not sterically blocked by surrounding
residues, suggesting that His58 and Glu62 could form the
catalytic pair while Lys84 and Arg90 stabilise the transi-
tion state of the nucleolytic reaction.
In an attempt to provide additional indirect evidence as to
the potential catalytic nature of His58, Glu62 and Arg90
we attempted to model an AG diribonucleotide into the
putative active site based on the binding of inhibitor D
(Cgac) to barnase (PDB code 1brn [42]; Figure 7).
However, the 5′-adenine base of the scissile dinucleotide
RNA substrate cannot be modelled directly by analogy
with the barnase complex due to unfavourable interactions
with the E3 protein in this position. It can, however, be
rotated such that the purine ring resides in a shallow
pocket on the surface of the enzyme with the aromatic ring
stacking against the guanidyl group of Arg40. This confor-
mation also allows hydrogen bonds to form between polar
groups on the base and other sidechains that surround the
groove. The ribose of the adenosine and 5′-phosphate of
guanylic acid were modelled based on structure 1brn and
adopt a conformation similar to that seen in other dipurine
diribonucleotides [43]. This places the 2′-hydroxyl adja-
cent to Glu62 and the scissile phosphorus–oxygen bond
proximal to His58. This again suggests that His58 and
Glu62 form the catalytic pair. The phosphate group is also
seen to be located close to the guanidinyl group of the
sidechain of Arg90, an ideal position for the stabilisation of
a pentacoordinate transition state. The 3′-guanylic acid is
modelled directly from 1brn and forms a loose stacking
interaction with the sidechain of His58. In the RNase
active site Glu62 forms an ion pair interaction with Arg90
which needs to be disrupted for substrate binding to occur
in the manner proposed by this model. However, it
appears that no other large-scale movement of residues is
required in order for the dinucleotide to bind. The model
also predicts that Thr31, Arg40 and Tyr64 are involved in
interaction with adenine 1493.
As it is likely that His58 and Glu62 are the catalytic
residues, this places the active site of the RNase at a loca-
tion distant to the site of Im3 binding. This mode of inhi-
bition is different to that seen in other RNase–inhibitor
complexes, as these involve direct binding to the active
site. Therefore, steric blockage of RNA entry to the active
site does not appear to be the mode of inhibition. Instead,
the role of the inhibitor may be to prevent the small
RNase domain from binding to the ribosome and hence
reaching its substrate. There are two ways in which this
could occur. The first is by steric hindrance, as binding of
the inhibitor creates a complex of ~45 Å in diameter. This
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Figure 7
The putative active site of colicin E3 cytotoxic domain. (a) The active-
site residues displayed in relation to the Im3-binding site. (b) An AG
diribonucleotide modelled into the active site to reveal a potential
binding pocket for adenine 1493.
is compared to a diameter of ~20 Å for the RNase alone.
The site of 16S RNA cleavage is situated in a narrow
groove in the ribosome [11] and so a twofold increase in
diameter on inhibitor binding could prevent the RNase
reaching its substrate. Alternatively, electrostatic repulsion
could prevent activity as the highly acidic immunity
protein could prevent the RNase from interacting with its
presumably acidic binding site on the ribosome.
Biological implications
Two classes of enzymatic E colicins have been charac-
terized. For the DNase colicins, structural data is now
available [14,22] giving insight into the residues involved
in catalysis and the mode of inhibition by their immunity
proteins. The structure of the E3–Im3 complex is the
first description of the fold of a ribosome-inactivating
RNase. The unique nature of the structure makes it
highly likely to form the basis of a new family of RNases
which lack the more commonly occurring motif of an
α helix packing across a β sheet. Sequence and struc-
tural analysis combined with molecular modelling has
revealed a putative active site within the toxin and sug-
gests that colicin E3 contains a His–Glu catalytic pair
similar to that seen in barnase. It has also revealed that
Arg90 is likely to be involved in stabilisation of the penta-
coordinate intermediate formed during RNA hydrolysis.
Although the overall fold is non-conserved, the similarity
in the distribution of catalytic residues to that seen in
other RNases implies that a process of convergent evolu-
tion has occurred to generate a functional enzyme.
The analysis of the protein–protein interface reveals an
extensive, highly complementary interaction surface which
involves both hydrophobic and hydrophilic residues in
binding — suggestive of a high-affinity complex. This
complex also provides an alternative model for the analy-
sis of protein–protein interactions that can be used in
parallel with the DNase colicin E9–Im9 system [17,22].
The site of inhibitor binding is distant from the catalytic
centre and does not appear to obscure the active site. This
is in contrast to the situation observed in other RNases
and suggests a more subtle form of inhibition is occur-
ring, which could involve the prevention of the RNase
binding to the ribosome by steric or electrostatic means.
It is also apparent that the active site involves residues
C-terminal to the site of inhibitor binding, which is anal-
ogous to the situation in the DNase colicins suggesting
that the immunity protein might bind to an incompletely
translated colicin in order to afford protection to the pro-
ducing bacterium as the toxin is being synthesised. 
Materials and methods
Structure determination
All data collection was performed at 100K using cryoprotected crys-
tals (15% (v/v) ethylene glycol, 0.1 M Na citrate pH 5.6, 15% (w/v)
PEG 4K, 20% (v/v) isopropanol). The space group was P3121, cell
parameters a = 92.8 Å, b = 92.8 Å, c = 77.2 Å with one molecule of
complex in the asymmetric unit. X-ray diffraction data were collected
from a single crystal of the mutant SeMet C47M Im3 complex with E3
[24] at three wavelengths around the selenium K-edge on station
BM14 at the ESRF (Grenoble, France). Images were processed using
DENZO [44] to 2.8 Å resolution. An additional data set was collected
from a single crystal of the native complex at a wavelength of 0.95 Å
on station 9.5 at the SRS (CLRC Daresbury Laboratory, UK) and
processed to 2.4 Å (native cell parameters a = 93.7 Å, b = 93.7 Å,
c = 76.2 Å). Scaling of the MAD data was performed using SCALA
[45] and the positions of the two selenium atoms were found using
SOLVE [46]. The resultant map from SOLVE had an average figure of
merit of 0.55–2.8 Å resolution. Phase improvement by solvent-flatten-
ing was performed using DM [47] at a nominal solvent content of
72%. This produced a phase set with a free R factor of 29.6%. The
initial electron-density map was of exceptional quality and displayed
clear solvent boundaries for the complex, and it was possible to trace
all 84 residues of the immunity protein and residues 2–94 in the
RNase domain (Phe455–Lys549) using O [48]. For refinement, 5% of
the reflections were set aside for the calculation of the Rfree [49].
Maximum likelihood refinement by simulated annealing using CNS
[50] produced a model with Rcryst = 30.1% (Rfree = 33.2%). Phase
combination using this model allowed the missing residues in the
RNase domain to be traced resulting in a complete model of both
RNase domain and immunity protein. Subsequent least squares min-
imisation using CNS resulted in a model with Rcryst = 28%
(Rfree = 31.0%). This model was then transformed to the crystallo-
graphic cell of the native complex by molecular replacement using
AMoRe [51] (with an R factor of 32.9% and a correlation coefficient
of 77.9%). Three further rounds of rebuilding and minimisation using
CNS followed producing a model with Rcryst = 26.9% (Rfree = 30.1%).
Refinement and optimisation of the B-factor model and optimisation of
stereochemical restraints were performed yielding a model with Rcryst
=23.8% (Rfree =27.8%). Inspection of single difference Fourier maps
at this stage showed residual electron density at > 6σ near to the
complex interface. This could be ascribed to an ordered ethylene mol-
ecule. A model of which was generated using HICUP [52] and fitted
to the density. Refinement with the ethylene glycol present converged
to give an Rcryst = 21.8% (Rfree = 25.4%). Finally water molecules were
added to residual density in the (Fo–Fc) difference Fourier map. A total
of 176 water molecules were added to 3σ peaks and refined using
CNS. At this stage the refinement converged to produce a final model
with Rcryst = 19.2% ( Rfree = 22.8%) for all data (applying a 2σ cut-off)
in the resolution range 30–2.4 Å. Analysis of the final model using
PROCHECK [53] showed 86.8% of the residues fall in the most
favoured regions of the Ramachandran plot, while the remaining
13.2% fell into allowed regions. No residues lie in generously allowed
or disallowed areas. Structural homology searches were performed
using DALI [28] and analysis of the interface was carried out using
programs from the CCP4 program suite [54], SPOCK [55],
SURFNET [34] and Sc [33]. Molecular modelling was performed
using the program INSIGHT98 (Insight II http//:www.msi.com). Figures
were produced using a combination of the programs MOLSCRIPT
[56], RASTER3D [57] and SPOCK [55]. 
Accession numbers
The atomic coordinates for the colicin E3 RNase domain complex with
Im3 have been deposited in the PDB (accession code 1e44).
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